Parma, Italy

Paolo Chiesi

This inventor holds 41 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 6 EPO patents, primarily in Pulmonary Surfactant. Top assignees: Chiesi Farmaceutici S.p.a., Chiesi Farmaceuticals S.p.a., Chinoin Pharmaceutical and Chemical Works Private Company Ltd.. Active years: 1986-2014.

USPTO Granted Patents = 41 

% Patents Active = 90.2

 

 

Average Co-Inventor Count = 2.9

ph-index = 13

Forward Citations = 611(Granted Patents)


Location History:

  • Fontanini di Vigatto, IT (1992)
  • Parma, IT (1986 - 2014)

Company Filing History:


Years Active: 1986-2014

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pulmonary Surfactant
Inhalation Delivery
Therapeutic Combinations
Aerosol Medicaments
Cardiovascular Diseases
Drug Particles
Pharmaceutical Compositions
Dry Powder Inhalers
Amino Acid Derivatives
Cholinesterase Inhibitors
Effervescent Formulations
Solubility Complexes
41 patents (USPTO):Explore Patents

Title: Paolo Chiesi - Innovative Inventor from Parma, Italy

Introduction: Paolo Chiesi is a renowned inventor hailing from Parma, Italy, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Paolo Chiesi holds several patents in the fields of biotechnology, pharmaceuticals, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Paolo Chiesi has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Paolo Chiesi has collaborated with top scientists, researchers, and industry experts, fostering a culture of innovation and excellence in all his projects.

Conclusion: Paolo Chiesi's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the global landscape of technology and science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…